文献速递瓣膜外科主动脉外科

既往主动脉瓣手术后的Ross手术:倾向加权的中期结局比较

The Ross Procedure After Previous Aortic Valve Surgery: Propensity-Weighted Comparison of Mid-Term Outcomes.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-09-27

该研究在Montreal心脏研究所分析816例成人Ross手术,其中83例为再手术Ross,733例为初次Ross。倾向重叠加权后,再手术Ross与更高的全因死亡率相关(HR 3.92, 95%CI 1.41-10.94, P=0.009),再干预率数值更高但无统计学意义。再手术组主动脉窦直径持续较大,提示既往手术不防止自体移植物根部扩张,需持续影像监测。

要点

  • 再手术Ross术后中期全因死亡率显著高于初次Ross(HR 3.92)。
  • 再干预率在再手术组数值更高但未达统计学显著(HR 2.68, P=0.069)。
  • 既往手术不保护自体移植物免受根部扩张,需持续影像监测。

核心结论

  • 成人既往心脏手术后行Ross手术可行,但再手术Ross与更高的中期全因死亡率相关。
  • 既往主动脉瓣手术不防止自体移植物根部进行性扩张,支持术后持续影像监测。

研究设计与样本

  • 回顾性队列分析816例2011-2025年在Montreal心脏研究所接受Ross手术的连续成人。
  • 83例(10.2%)为再手术Ross,733例(89.8%)为初次Ross;采用倾向评分重叠加权平衡9个预设协变量,1:1倾向匹配作为敏感性分析。

主要发现

  • 手术死亡率为再手术组2.4% vs 初次组0.3%(P=0.054)。
  • 中位随访5.0年(IQR 1.6-8.4),重叠加权后再手术Ross与更高的全因死亡率相关(HR 3.92, 95%CI 1.41-10.94, P=0.009)。
  • 再干预率数值更高但无统计学意义(HR 2.68, 95%CI 0.93-7.75, P=0.069)。
  • 再手术组从术后至10年主动脉窦Valsalva直径绝对值持续较大,扩张速率不同;免于自体移植物反流≥2+的比例相当。

临床怎么用

  • 成人既往主动脉瓣手术后可行Ross手术,但需权衡更高的中期死亡风险。
  • 无论是否有既往手术史,Ross术后均应持续影像监测自体移植物根部扩张。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to compare mid-term clinical, hemodynamic, and reintervention outcomes of the Ross procedure performed in primary versus reoperative settings in adults. METHODS: We analyzed 816 consecutive adults undergoing the Ross procedure at the Montreal Heart Institute between 2011 and 2025: 83 (10.2%) underwent a Ross after at least one prior aortic valve operation (redo Ross) and 733 (89.8%) underwent primary Ross. Propensity-score overlap weighting balanced nine pre-specified covariates (age, sex, NYHA, left ventricular ejection fraction, bicuspid morphology, pure aortic stenosis, pure aortic regurgitation, endocarditis, and preoperative aortic regurgitation grade); 1:1 propensity matching served as sensitivity. Survival was compared using overlap-weighted Kaplan-Meier. Reintervention was modeled with Aalen-Johansen competing-risk methods. Longitudinal echocardiographic trajectories were analyzed with weighted generalized estimating equations. RESULTS: Operative mortality was 2.4% (redo) versus 0.3% (primary, P=0.054). Over a median follow-up of 5.0 years (IQR 1.6-8.4), redo Ross was associated with higher all-cause mortality after overlap weighting (HR 3.92, 95% CI 1.41-10.94, P=0.009). Reintervention was numerically more frequent (HR 2.68, 95% CI 0.93-7.75, P=0.069) but not statistically significant. The redo group exhibited a consistently larger absolute sinus of Valsalva diameter from the postoperative period through ten years, with differing dilation rates. Freedom from autograft regurgitation ≥ 2+ was comparable. CONCLUSIONS: The Ross procedure can be performed safely in adults after prior cardiac surgery. Prior surgery does not protect the autograft against progressive root dilatation in adults, supporting continued imaging surveillance irrespective of operative history.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sarshoghi A, Ajmi N, Noly PE, et al. The Ross Procedure After Previous Aortic Valve Surgery: Propensity-Weighted Comparison of Mid-Term Outcomes. J Thorac Cardiovasc Surg. 2026. PMID: 42801971. doi:10.1016/j.jtcvs.2026.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。